Search Results - "Snyder, Courtney"

Phase II clinical trial of nab‐paclitaxel plus cisplatin plus gemcitabine (NABPLAGEM) in patients with untreated advanced pancreatic cancer by Jameson, Gayle S., Hosein, Peter J., Pierce, Erin, Kamgar, Mandana, Gordon, Michael S., Snyder, Courtney, Roe, Denise J., Wertheim, Betsy C., Davey, Marina, Barrett, Michael T., Von Hoff, Daniel D., Borazanci, Erkut

“…Background A previous phase IB/II study of nab‐paclitaxel + cisplatin + gemcitabine (NABPLAGEM) in 25 patients with previously untreated metastatic pancreatic…”
Get full text

Considering Point-of-Care Electronic Medical Resources in Lieu of Traditional Textbooks for Medical Education by Hale, LaDonna S, Wallace, Michelle M, Adams, Courtney R, Kaufman, Michelle L, Snyder, Courtney L

“…Selecting resources to support didactic courses is a critical decision, and the advantages and disadvantages must be carefully considered. During clinical…”
Get full text

Effects of Exogenous and Endogenous Distracters on Immediate and Long-Term Recall in Toddlers by Dixon Jr, Wallace E., Lawman, Hannah G., Johnson, Elizabeth B. H., May, Sarah, Patton, Leslie A., Lowe, Allison K., Snyder, Courtney M.

“…We explored the role that exogenous and endogenous competitors for attention play in infants’ abilities to encode and retain information over a 6‐month period…”
Get full text

Conducting Expressively: Navigating Seven Misconceptions That Inhibit Meaningful Connection to Ensemble and Sound by Snyder, Courtney

“…When expressivity (ignited by imagination) is incorporated into the learning process for both the conductor (teacher) and player (student), the qualities of…”
Get full text

Paclitaxel protein bound (A) plus gemcitabine (G) plus cisplatin (C) and hydroxychloroquine (HCQ) neoadjuvant therapy for localized pancreatic ductal adenocarcinoma (PDAC) by Borazanci, Erkut Hasan, Jameson, Gayle S., Snyder, Courtney Edwards, Thosani, Amar, Sckolnik, Steven, Korn, Ronald Lee, Rahmanuddin, Syed, Mocan, Dan, Pearse, Shelby, Gordon, Michael S., Von Hoff, Daniel D., Modasi, Aryan, Amini, Albert

“…667 Background: Neoadjuvant therapy has become the consensus treatment for individuals with locally advanced (LA) and borderline resectable (BR) PDAC…”
Get full text

Abstract PO-015: A phase Ib/II trial of high dose ascorbic acid (AA) + paclitaxel protein bound (PP) + cisplatin (C) + gemcitabine (G) in patients (pts) with previously untreated metastatic pancreatic cancer (MPC) by Jameson, Gayle S., Borazanci, Erkut H., Von Hoff, Daniel D., Rabinowitz, Joshua D., Gordon, Michael S., LeGrand, Sarah D., Snyder, Courtney, Ansaldo, Karen, Roe, Denise J., Han, Haiyong

“…Abstract Background: Increasing evidence suggests that high concentrations of AA (vitamin C) can decrease the growth of aggressive tumors, including Ras-mutant…”
Get full text

Hand therapy interventions for the prevention of chemotherapy-induced peripheral neuropathy of the hands in patients with pancreatic cancer by Jameson, Gayle S, Cooper, Cynthia, Snyder, Courtney, Buchanan, Sharon M, Strelish, Terri, Shearon, Tania, Von Hoff, Daniel D, Bay, Curt, Hull, Lynne, Kaatz, Lorilyn A, Borazanci, Erkut H

“…Chemotherapy-induced peripheral neuropathy (CIPN), a common problem, can impair function and quality of life in patients, potentially limiting chemotherapy and…”
Get full text

An Analysis of Patients with DNA Repair Pathway Mutations Treated with a PARP Inhibitor by Borazanci, Erkut, Korn, Ronald, Liang, Winnie S., Guarnieri, Carol, Haag, Susan, Snyder, Courtney, Hendrickson, Kristin, Caldwell, Lana, Von Hoff, Dan, Jameson, Gayle

“…Background Molecular analysis has revealed four subtypes of pancreatic ductal adenocarcinoma (PDAC). One subtype identified for the presence of DNA damage…”
Get full text

Abstract B27: A phase Ib/II trial of high-dose (HD) ascorbic acid (AA) + paclitaxel protein bound (PP) + cisplatin (C) + gemcitabine (G) in patients (pts) with metastatic pancreatic cancer (MPC) by Jameson, Gayle S., Borazanci, Erkut H., Rabinowitz, Joshua, Ansaldo, Karen, LeGrand, Sarah, Propper, David, Snyder, Courtney, Gordon, Michael, Roe, Denise, Hoff, Daniel D. Von

“…Abstract Introduction: Based on the unmet medical need in MPC, its high frequency of Ras mutations, and prior work combining PP + C + G demonstrating an…”
Get full text

Prospective study of early detection of malignancies in individuals at risk for developing pancreatic cancer by Snyder, Courtney Edwards, Haag, Susan, Adams, Domenica, Paskett, Breann, Hess, Jade, Borazanci, Erkut Hasan

“…Abstract only TPS500 Background: It is estimated that by 2030 pancreatic cancer will be the second leading cause of cancer deaths in the US. Currently, only 9%…”
Get full text

Abstract B18: Improving pancreatic cancer risk prediction through early detection by Snyder, Courtney, Haag, Susan G., Adams, Nickie, Hess, Jade, Paskett, Breann, Borazanci, Erkut

“…Abstract Introduction: It is estimated that by 2030 pancreatic cancer will be the second leading cause of cancer deaths in the US. Currently, only 9% of newly…”
Get full text

Abstract B05: Paclitaxel protein bound plus gemcitabine plus cisplatin and paricalcitol neoadjuvant therapy for localized pancreatic ductal adenocarcinoma (PDAC) by Borazanci, Erkut, Jameson, Gayle, Snyder, Courtney, Tsai, Frank, Gordon, Michael, Sharma, Sunil, Guarnieri, Carol, Thosani, Amar, Rahmanuddin, Syed, Korn, Ronald, Sckolnik, Steven, Sedivy, Paula, Haag, Susan, Gosselin, Kevin, Hoff, Daniel Von, Amini, Albert

“…Abstract Background: Localized PDAC management has recently evolved. Due to concerns over micrometastases at diagnosis, the use of neoadjuvant chemotherapy for…”
Get full text

Retrospective analysis of patients using olaparib (O) in pancreatic cancer (PC) by Borazanci, Erkut Hasan, Guarnieri, Carol, Haag, Susan, Korn, Ronald Lee, Snyder, Courtney Edwards, Hendrickson, Kristin, Caldwell, Lana, Von Hoff, Daniel D.

“…Abstract only 389 Background: Molecular analysis has revealed four subtypes of PC giving clinicians further insight into treating this deadly disease. One…”
Get full text

Paclitaxel protein bound (A) plus gemcitabine (G) plus cisplatin (C), and paricalcitol (P)neoadjuvant therapy for localized pancreatic ductal adenocarcinoma (PDAC) by Borazanci, Erkut Hasan, Jameson, Gayle S., Snyder, Courtney Edwards, Tsai, Frank Yung-Chin, Gordon, Michael S., Sharma, Sunil, Guarnieri, Carol, Thosani, Amar, Rahmanuddin, Syed, Korn, Ronald Lee, Sckolnik, Steven, Salontai, Sharon, Wyman, Rachel, Haag, Susan, Gosselin, Kevin, Von Hoff, Daniel D., Amini, Albert

“…Abstract only 4631 Background: Localized PDAC management has recently evolved. Due to concerns over micro metastases at diagnosis the use of neoadjuvant…”
Get full text

Cost Containment May Have a Price, But Is It a Crime? Analyzing the Basis for Criminalizing Managed Care Conduct by Snyder, Courtney Lyons

“…A recent transplant case raises an interesting question: Should a managed care organization (“MCO”) face criminal prosecution when a patient dies after the…”
Get full text

The Effect of Task Difficulty on Preschoolers' Problem-Solving and Emotion-Regulation Strategy use by Snyder, Courtney Marie

“…Although there has been a lot of research on problem-solving and emotion-regulation independently, little work has been done on how these constructs are…”
Get full text

Smoky by Snyder, Courtney

“…A child's poem is presented…”
Get full text